EC
BITI

EcoR1 Capital’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

EcoR1 Capital’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-100,000
Closed -$2M – 32
2015
Q2 		$2M Buy
+100,000
New +$2.09M 0.67% 19

Other funds holding BITI

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

EcoR1 Capital's BITI Position: Q3 2015 in Review

EcoR1 Capital sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q3 2015, closing a stake of 100,000 shares — an estimated $2M sold.

EcoR1 Capital first reported a position in BITI in Q2 2015 and held it in 1 quarter. The position peaked at $2M in Q2 2015. 15 funds tracked by Wall St. Rank hold BITI as of Q3 2015.

  • EcoR1 Capital reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q3 2015 after selling out during the quarter.
  • EcoR1 Capital sold 100,000 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q3 2015, an estimated $2M.
  • EcoR1 Capital first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 1 quarter.
  • EcoR1 Capital's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $2M in Q2 2015.
  • 15 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q3 2015.

Based on EcoR1 Capital's 13F filing for Q3 2015, filed 16 Nov 2015.